DHC — Diversified Healthcare Trust

Summary of DHC Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Normalized FFO: $33.1 million, or $0.14 per share, exceeding analyst expectations.
• Adjusted EBITDAre: $74 million, also above consensus estimates.
• Consolidated NOI: Increased 4.7% year-over-year to $75.9 million.
• Same-property SHOP NOI: Rose 13.5% year-over-year to $44.3 million, driven by occupancy growth of 110 basis points and average monthly rate growth of 5.9%.
• Same-property NOI margin: Expanded by 160 basis points to 14.9%.
• Total liquidity: $272 million, including $122 million in cash and $150 million available under a secured revolving credit facility.
• Net debt to annualized adjusted EBITDAre: Improved to 7.8x from 8.8x year-over-year.

2. Strategic Updates and Business Highlights

• Continued focus on active asset management and partnerships with best-in-class operators.
• Implementation of new dietary and food contracts, leading to cost savings and improved resident experience.
• Capital deployment strategy includes repositioning underutilized skilled nursing wings into independent living or assisted living, with an initial investment of approximately $20 million expected to add 150 units.
• Strong performance in the Medical Office and Life Science portfolio, with same-property occupancy increasing to 95.3%.

3. Forward Guidance and Outlook

• Reaffirmed 2026 guidance:
  • SHOP NOI: $175 million to $185 million.
  • Medical Office and Life Science NOI: $94 million to $98 million.
  • Adjusted EBITDAre: $290 million to $305 million.
  • Normalized FFO: $0.52 to $0.58 per share.
• Anticipated continued growth in SHOP NOI, driven by improved expense management and occupancy increases.

4. Bad News, Challenges, or Points of Concern

• Occupancy Rates: Same-property occupancy in the SHOP segment remained flat quarter-over-quarter, attributed to both seasonality and the transitional phase with new operators.
• G&A Expenses: Increased due to incentive management fees linked to stock performance, which could affect overall profitability.
• Market Conditions: Potential risks from competitive pressures and the impact of ongoing transitions from previous operators.

5. Notable Q&A Insights

• Management confirmed that the recurring CapEx guidance includes both maintenance and refresh capital, with expectations for a modest pullback in maintenance costs over time.
• The focus for new investments will primarily be on renovations rather than acquisitions, leveraging existing portfolio opportunities.
• The transition from AlerisLife is progressing well, with incremental benefits expected as new operators optimize operations.
• There is a cautious outlook on occupancy growth, with expectations for a 300 basis point increase year-over-year, but some seasonal fluctuations anticipated in the second half of 2026.

This summary encapsulates the key points from DHC's Q1 2026 earnings call, highlighting both the positive developments and the challenges the company faces moving forward.